We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBI icon
1501
Pitney Bowes
PBI
$2.28B
$876K ﹤0.01%
82,876
-15,231
-16% -$158K
MNKD icon
1502
MannKind Corp
MNKD
$1.2B
$875K ﹤0.01%
154,254
-16,756
-10% -$92.3K
BHE icon
1503
Benchmark Electronics
BHE
$2.94B
$874K ﹤0.01%
20,444
-1,014
-5% -$43.9K
IPAR icon
1504
Interparfums
IPAR
$3.78B
$873K ﹤0.01%
10,293
-136,778
-93% -$12M
LZB icon
1505
La-Z-Boy
LZB
$1.64B
$872K ﹤0.01%
23,397
-1,398
-6% -$49K
DGII icon
1506
Digi International
DGII
$3.23B
$872K ﹤0.01%
20,134
-1,093
-5% -$43.8K
ELME
1507
Elme Communities
ELME
$144M
$871K ﹤0.01%
50,034
-1,921
-4% -$32.6K
FIVN icon
1508
FIVE9
FIVN
$2.53B
$869K ﹤0.01%
43,317
-2,329
-5% -$49.4K
HTH icon
1509
Hilltop Holdings
HTH
$2.25B
$867K ﹤0.01%
25,533
-1,497
-6% -$50.2K
TNDM icon
1510
Tandem Diabetes Care
TNDM
$1.61B
$859K ﹤0.01%
39,091
RXRX icon
1511
Recursion Pharmaceuticals
RXRX
$1.78B
$858K ﹤0.01%
209,801
-5,439
-3% -$26.9K
SHO icon
1512
Sunstone Hotel Investors
SHO
$2.01B
$858K ﹤0.01%
95,927
-17,247
-15% -$158K
ENOV icon
1513
Enovis
ENOV
$1.42B
$856K ﹤0.01%
32,142
-1,965
-6% -$58.1K
PAYO icon
1514
Payoneer
PAYO
$2.42B
$853K ﹤0.01%
151,731
-8,149
-5% -$47.1K
CENTA icon
1515
Central Garden & Pet Co Class A
CENTA
$2.43B
$850K ﹤0.01%
29,118
MBC icon
1516
MasterBrand
MBC
$1.89B
$845K ﹤0.01%
76,519
BLBD icon
1517
Blue Bird Corp
BLBD
$2.04B
$845K ﹤0.01%
17,973
-833
-4% -$43.6K
ROCK icon
1518
Gibraltar Industries
ROCK
$1.46B
$844K ﹤0.01%
17,071
NEO icon
1519
NeoGenomics
NEO
$2.11B
$844K ﹤0.01%
71,734
+1,524
+2% +$16.4K
STBA icon
1520
S&T Bancorp
STBA
$1.82B
$842K ﹤0.01%
21,408
-1,201
-5% -$46.4K
DVAX
1521
DELISTED
Dynavax Technologies
DVAX
$842K ﹤0.01%
54,723
-3,186
-6% -$35.1K
AXGN icon
1522
Axogen
AXGN
$2.58B
$840K ﹤0.01%
25,657
AIN icon
1523
Albany International
AIN
$1.81B
$838K ﹤0.01%
16,522
-943
-5% -$48.8K
OLMA icon
1524
Olema Pharmaceuticals
OLMA
$920M
$838K ﹤0.01%
33,500
-4,120
-11% -$73.3K
ZD icon
1525
Ziff Davis
ZD
$1.92B
$837K ﹤0.01%
23,826
-1,259
-5% -$43.9K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.